Lazard Capital Starts AVI BioPharma (AVII) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Wall St set for higher open as SpaceX, Super Micro results rekindle AI trade
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- AI bubble about to burst? Not yet, Yardeni says
- SpaceX tops Q3 estimates as revenue surges 161% on Starlink, AI compute expansion
Tweet
Share
E-mailGet Alerts AVII Hot Sheet
Price: $0.66 --0%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 17 | New: 13
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 17 | New: 13
Join SI Premium – FREE
Lazard Capital initiates coverage on AVI BioPharma (NASDAQ: AVII) with a Buy. PT $5.00.
For more ratings news on AVI BioPharma click here and for the rating history of AVI BioPharma click here.
Shares of AVI BioPharma closed at $1.16 yesterday.
For more ratings news on AVI BioPharma click here and for the rating history of AVI BioPharma click here.
Shares of AVI BioPharma closed at $1.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Guggenheim Starts Kazia Therapeutics (KZIA) at Buy
- Noble Capital Starts NetSol Tech (NTWK) at Outperform
- Nomura/Instinet Starts NTPC Green Energy (NTPCGREE:IN) at Neutral
Create E-mail Alert Related Categories
New CoverageRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
